Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant

Knop, Stefan and Langer, Christian and Engelhardt, Monika and Muegge, Lars-Olof and Reichle, Albrecht and Roesler, Wolf and Bassermann, Florian and Hertenstein, Bernd and Sturm, Isrid and Roellig, Christoph and Ostermann, Helmut and Schaefer-Eckart, Kerstin and Ringhoffer, Mark and Guenther, Andreas and Junghanss, Christian and Biersack, Harald and Strifler, Susanne and Bachinger, Andreas and Einsele, Hermann and Bargou, Ralf C. (2014) Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant. BLOOD, 124 (21): 177. ISSN 0006-4971, 1528-0020

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 13 Aug 2020 14:28
Last Modified: 13 Aug 2020 14:28
URI: https://pred.uni-regensburg.de/id/eprint/9064

Actions (login required)

View Item View Item